Price movement over the last 24 hours
Abbott Laboratories vs Ishares Msci Spain ETF — how do they compare? Abbott Laboratories trades at $95.21 (market cap $166.94B), while Ishares Msci Spain ETF trades at $58.67. The key difference: Abbott Laboratories pays a 2.63% dividend while Ishares Msci Spain ETF pays none, and Ishares Msci Spain ETF is trading nearer its 52-week high, Abbott Laboratories nearer its low. Which is the better fit depends on your goals.
| ABT | EWP | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $136.62 | $60.28 |
52-Week Low | $82.57 | $43.48 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
EWP trades at $60.28, up 1.04% today, with strong bullish technical signals from moving averages and a neutral RSI. The stock shows momentum above key support levels. Recent news highlights European market strength, with Spain's GDP outperforming the Eurozone, potentially benefiting EWP's regional exposure. A dividend of $0.92 is scheduled for June 2026, adding income appeal.
Outlook is cautiously optimistic due to technical strength and positive European economic trends, but fundamental data is limited. Risks include European regulatory probes and energy price volatility. Investors should monitor upcoming financial disclosures for valuation clarity amid current data gaps.
Trailing returns across standard periods
Latest headlines on both assets
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →EWP is a country-specific ETF that tracks the performance of the Spanish equity market. It provides targeted access to large and mid-sized companies in Spain, with heavy weightings in financials and utilities like Banco Santander and Iberdrola.
Read more on EWP →